Biotech stocks are at a record high
The iShares Nasdaq Biotechnology ETF rallied more than 3% on Thursday to a new all-time high.
The ETF, which tracks stocks in the industry, has seen two big plunges this year, including a 10% correction in April.
Despite these zigzags, the trend is up, and the industry has rallied with other stocks on the market today to reach a new peak.
Earlier on Thursday, the Nasdaq crossed its previous intraday high set in March 2000.
The biotech ETF is now up more than 50% from mid-July last year, when Federal Reserve chair Janet Yellen said that biotech stock valuations "appear substantially stretched."
Yellen has been joined by several Wall Street analysts, who believe the sector is in a bubble, waiting to burst.
Here's a chart showing the sector's climb since 2010.
Google Finance
h/t StockTwits
- Love in the time of elections: Do politics spice up or spoil dating in India?
- Samsung Galaxy S24 Plus review – the best smartphone in the S24 lineup
- Household savings dip over Rs 9 lakh cr in 3 years to Rs 14.16 lakh cr in 2022-23
- Misleading ads: SC says public figures must act with responsibility while endorsing products
- Here’s what falling inside a black hole would look like, according to a NASA supercomputer simulation